Jan Orwar

Jan Orwar

Director/Board Member at FLUICELL AB
62 year
Consumer Services
Commercial Services
Health Technology

Profile

Jan Owe Owesson Orwar was the founder of Cellectricon AB, founded in 2000, where the title held was Director & Chief Scientific Officer.
Dr. Orwar is the founder of Nanoxis AB, founded in 2002, where the title held was Director & Chief Scientific Advisor from 2002 to 2014.
Dr. Orwar is also the founder of Oblique Therapeutics AB. Dr. Orwar is currently Director-Bioeletronics & Bio-Computing Program at Chalmers University of Technology since 2011.
Dr. Orwar is currently Director at Fluicell AB since 2015.
Dr. Orwar is currently Senior Group Leader at Karolinska Institutet.
Former positions include President-Research & Development at Piramal Enterprises Ltd. and Global Vice President-Research & Development at Sanofi AB. Education includes doctorates from Stanford University and the University of Gothenburg.

Jan Orwar active positions

CompaniesPositionStart
FLUICELL AB Director/Board Member 2014-12-31
Corporate Officer/Principal 2011-01-16
Corporate Officer/Principal -

Former positions of Jan Orwar

CompaniesPositionEnd
Founder 2014-02-10
PIRML ENT Chief Tech/Sci/R&D Officer -
Chief Tech/Sci/R&D Officer -
Chief Executive Officer -
Founder -
See the detail of Jan Orwar's experience

Training of Jan Orwar

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

93

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Commercial Services

Consumer Services

Finance

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

Distribution Services

Health Technology